• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
GERN

GERN

Geron Corporation

NASDAQHealthcareBiotechnologyUS

USD1.16

-0.01 (-0.85%)

Rating:D+

Company Profile

CEO

Harout Semerjian

IPO Date

1996-07-31

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$1.19

Prev. Close

$1.17

Day Low

$1.14

Day High

$1.19

52W Low

$1.04

52W High

$2.01

Market Cap

$0.74B

Volume

9.98M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

36.9%

Avg Negative

14.9%

Avg Neutral

48.1%

News Feed

Do Options Traders Know Something About Geron (GERN) Stock We Don't?

Zacks Investment Research·6/21/2021·↓ negative

Geron: End Of The Tunnel

Seeking Alpha·6/21/2021·↓ negative

Why Geron Stock Is Soaring Today

The Motley Fool·6/18/2021·↑ positive

Geron Stock Trading Is Higher On Reinforcing Imetelstat's Approach For Myelofibrosis Treatment, With Data Publication In Journal

Benzinga·6/18/2021·↑ positive

GERN Stock Price Increases Over 30% Pre-Market: Why It Happened

Pulse2·6/18/2021·↑ positive

Geron Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology

Business Wire·6/17/2021·↑ positive

Geron Reports Two Presentations at Virtual European Hematology Association Annual Congress

Business Wire·6/14/2021·↑ positive

Geron Announces Two Presentations at Upcoming European Hematology Association Annual Congress

Business Wire·5/12/2021·↑ positive

Geron Corporation (GERN) CEO John Scarlett on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/10/2021·↓ negative

Geron: Q1 Earnings Insights

Benzinga·5/10/2021·↓ negative